Katz, Marshall & Banks associate Joseph Abboud wrote an article in Bloomberg Law, “INSIGHT: Strong Whistleblower Protections Are Vital During COVID-19.”
Now more than ever, the public is depending on government officials and health care providers to act with the utmost care and integrity during the COVID-19 pandemic. Yet, none of the Coronavirus relief legislation passed by Congress so far has included anti-retaliation provisions to encourage the reporting of fraudulent or abusive practices. And broadly, on the federal level, there is currently no law that protects healthcare whistleblowers from retaliation. Furthermore, the federal law governing workplace safety, the Occupational Safety and Health Act, does not allow workers to sue their employers for retaliation.
Mr. Abboud argues for Congress to pass a law that creates permanent whistleblower protections for employees who report risks to public health and safety. Not only will this discourage retaliation, but it will likely spur health care institutions to prioritize patient safety over financial considerations.
Read the full article here.